53
Views
12
CrossRef citations to date
0
Altmetric
Original Research

The reasons for triple therapy in stable COPD patients in Japanese clinical practice

, , , , , , , , , , , & show all
Pages 1053-1059 | Published online: 04 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Roland Buhl, Thomas Wilke, Nils Picker, Olaf Schmidt, Marlene Hechtner, Anke Kondla, Ulf Maywald & Claus F Vogelmeier. (2022) Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2355-2367.
Read now
Wei-Chun Huang, Chih-Yu Chen, Wei-Chih Liao, Biing-Ru Wu, Wei-Chun Chen, Chih-Yen Tu, Chia-Hung Chen & Wen-Chien Cheng. (2021) A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1555-1568.
Read now
Leah B Sansbury, Chanchal Bains, David A Lipson, Afisi S Ismaila & Sarah H Landis. (2021) Real-World Treatment Patterns of Multiple-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in UK General Practice. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1255-1264.
Read now
Lowie Vanfleteren, Leonardo M Fabbri, Alberto Papi, Stefano Petruzzelli & Bartolome Celli. (2018) Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3971-3981.
Read now
Tomoko Betsuyaku, Motokazu Kato, Keisaku Fujimoto, Akihiro Kobayashi, Tomoyuki Hayamizu, Hideki Hitosugi, Gerald Hagan, Mark H James & Paul W Jones. (2018) A randomized trial of symptom-based management in Japanese patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2409-2423.
Read now
Shotaro Chubachi, Saeko Takahashi, Akihiro Tsutsumi, Naofumi Kameyama, Mamoru Sasaki, Katsuhiko Naoki, Kenzo Soejima, Hidetoshi Nakamura, Koichiro Asano & Tomoko Betsuyaku. (2017) Radiologic features of precancerous areas of the lungs in chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1613-1624.
Read now
Michele R Wilson, Jeetvan G Patel, Amber Coleman, Cheryl L McDade, Richard H Stanford & Stephanie R Earnshaw. (2017) Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 997-1008.
Read now
Mario Cazzola, Paola Rogliani, Josuel Ora & Maria Gabriella Matera. (2016) Treatment options for moderate-to-very severe chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 17:7, pages 977-988.
Read now
Minako Sato, Shotaro Chubachi, Mamoru Sasaki, Mizuha Haraguchi, Naofumi Kameyama, Akihiro Tsutsumi, Saeko Takahashi, Hidetoshi Nakamura, Koichiro Asano & Tomoko Betsuyaku. (2016) Impact of mild exacerbation on COPD symptoms in a Japanese cohort. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 1269-1278.
Read now
Guy Brusselle, David Price, Kevin Gruffydd-Jones, Marc Miravitlles, Dorothy L Keininger, Rebecca Stewart, Michael Baldwin & Rupert C Jones. (2015) The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 2207-2217.
Read now

Articles from other publishers (2)

F. Blasi, G. W. Canonica & M. Miravitlles. (2017) Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?. Respiratory Research 18:1.
Crossref
Štefan Laššán, Monika Laššánová, Jana Tisoňová & Peter Krištúfek. (2016) Summary. Klinická farmakologie a farmacie 30:1, pages 22-29.
Crossref